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TECHNICAL NOTE
An estimate of /32-microglobulin deposition rate in uremic
patients on hemodialysis using a mathematical kinetic model
TosHIYuIu KANAMORI and KJYOTAKA SAKAI
Department of Chemical Engineering, Waseda University, Tokyo, Japan
Since beta-2-microglobulin (f32m) was identified as the principal
protein causing dialysis-induced amyloidosis by a biochemical
procedure in 1985 [1], many types of hemodialysis membranes and
adsorbents which are capable of removing the protein from
patients have been developed. New treatment modalities, such as
hemodiafiltration with a large quantity of replacement fluid and
continuous hemofiltration, have also been generated to increase
2m removal,
The turnover and disappearance rates of 132m in normal
humans and patients with chronic renal diseases have been
reported [2—7]. However, the f32m deposition rate closely related
to formation of amyloid deposits has not been estimated, which
leads to difficulty in reliably evaluating new treatment devices and
modalities such as described above,
In the present study, a mathematical kinetic model based on
that reported by Karlsson et al 131 is presented. Time courses of
2m concentration in patients on hemodialysis are then discussed
using the model. Parameters required to calculate the model are
determined by fitting the time courses to clinical data previously
reported in the literature, thus providing an estimate of f32m
deposition rate.
Methods
A mathematical kinetic model for transports of j32m and body
fluid in a human body
Differential equations representing time courses of 2m and
body fluid in a human body were set up on the basis of a
two-compartment model illustrated in Figure 1. The compart-
ments consist of only the intra- and extravascular fluids where f32m
can be distributed. Beta-2-microglobulin is generated in the
intravascular fluid, transferred from one compartment to the
other according to the difference in J32m concentration between
the intra- and extravascular fluids, and discharged through kidney
and a few extrarenal pathways at each constant rate. These
assumptions are based on the model presented by Karlsson et a!
[3], and are the premises of the present model.
It is reasonable to assume that changes in body fluid volume
caused by oral intakes and filtration during a hemodialysis treat-
ment are instantly allotted to each compartment according to the
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volumes of the compartments, because transfer rates of water
through blood vessel and cell walls are much larger than those of
a solute with larger molecular weight such as /32m [8]. Mass
balance in each compartment and the above assumptions provide
the following differential equations for the intravascular compart-
ment:
d(V1C1)
dt
= G + Kw(Ca — XC1) — (KR + KER + CL)CI, (1)
and for the extravascular compartment,
d(VECE)
-
- KW(CE-XC1),dt (2)
where V (ml) denotes fluid volume in a compartment, C (mg/mI)
is f32m concentration of fluid, t (mm) time, K (ml/min) transfer or
discharging rate of 2m, X (—) equilibrium partition coefficient
between intra- and extravascular fluids, G (mg/mm) generation
rate of 132m and CL (mi/mm) clearance of a dialyzer. Regarding
the subscripts, I means intravascular, E is extravascular, W blood
vessel wall, R renal and ER extrarenal. The parameters of G, K,
X, KR, KER and CL are regarded as independent of time and are
constant for each patient.
The intra- and extravascular compartments correspond to
plasma and interstitial fluids, respectively. Volume ratios of
intracellular fluid, interstitial fluid and plasma to total body fluid
in a standard human body are 2/3, 1/4 and 1/12, respectively [9],
leading to the following equations relating to the mean water
intake rate W (mI/mm) and filtration rate during hemodialysis °F
(ml/min) with changes in each fluid volume,
dVE 1
= (W - OF)
dV1 1
(3)
(4)
Values of °F were constant during each hemodialysis treatment
and were provided to make the patient body weight equal to the
dry weight after the treatment.
Clearance of a dialyzer (C4) increasing with the filtration rate
(OF) was estimated by
CL = C + TROF (5)
where CLD denotes diffusion clearance of the dialyzer at Q1 = 0
and TR is a constant called "transmittance coefficient" [10].
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Fig. 1. Schematic of two-compartment model for
f32m in a patient without residual renal function.
Values of TR were fixed at 0 for conventional dialyzers and 0.5 for
high performance dialyzers in the present study.
Here, time courses of 2m concentration and body fluid volume
in a patient are calculated from the simultaneous differential
equations from Eq. 1 to 5, if the nine parameters, namely, G, K,
X, KR, KER, V, V1, CLD and TR, are obtainable. However, it is
impossible to determine immediately these parameters, except
those of dialyzer performance, that is, CLD and TR. In general, the
parameters are determined to provide minimum deviation of
calculated values from the observed ones. In this study, we used
the parameters previously presented in the literature and esti-
mated by reasonable assumptions as follows.
Dry weight of a patient was constant at 60 kg and values of V
and V1 were 8,000 and 4,000 ml, respectively, under the dry
condition. Only patients without residual renal function were
treated to make discussion clear, leading to eliminating urine
generation and K in Eq. l.A value ofXwas fixed at 1.0. A value
of K was constant at a value of 40 ml/min, the same as was
reported by Takesawa et al [11]. The values of X and K had no
significant influence on the results of the present study and were
previously confirmed by calculations varying these values. A value
of W was constant at a value of 1 ml/min corresponding to 1,44
liters per day. Values of CL were 0 ml/min for a standard
conventional dialyzer and during interdialytic periods.
Incidentally, the Runge-Kutta-Gill method with a differential
time of one minute was adopted to obtain the solutions of the
simultaneous differential equations, because it was very difficult to
solve the equations analytically.
Results and discussion
Time courses of 132m concentration in a patient treated with
conventional dialyzers
Even if a patient without residual renal function is treated with
conventional dialyzers incapable of removing f32m, the j32m
concentration in the patient is maintained at a certain level,
because the generation and extrarenal disappearance rates of 132m
are evenly balanced. Therefore, the following equation is derived
from mass balance in the patient body fluid:
G = KERCI (6)
where C5 is equal to the 2m concentration in the patient plasma.
This relation supports the notion that C1 is approximately con-
stant and independent of the other parameters such as K, X, V1
and V.
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Fig. 2. Time courses of intra- and extravascular
concentration of f32m and extracellular fluid
volume in a patient treated with conventional
dialyzers calculated by the mathematical kinetic
model. Symbols are: (—) C1; (0) CE.
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Fig. 3. Deposition rate of j32m MD in a patient treated with conventional
dialyzers.
Figure 2 represents time courses of 2m concentrations C1, CE
and extracellular fluid volume (V1 + VE) calculated by the
mathematical kinetic model in such a patient as is mentioned
above. Three treatments per week (Monday, Wednesday and
Friday) and four hours per each treatment were assumed.
The results of the present study depend mainly on the balance
between the generation and disappearance rates of 132m. The
disappearance rate, which is the sum of extrarenally discharging
rate and dialyzer clearance, is discussed below. Therefore, gener-
ation rate G is a very important factor in the present study.
Karisson et al [31 have determined the fJ2m generation rates to
be 0.131 0.0233 mg/hr/kg for six normal persons using 12s1
labeled /32m. Ode!! et a! [6] and F!oege et al [7] have also
determined that the generation rate using similar methods is 0.159
0.0414 mg/hr/kg and 0.129 0,0329 mg/hr/kg, respective!y, for
patients on hemodialysis. Maeda et a! [4] have estimated the
generation rate at 0.130 0.029 mg/hr/kg using the data for
patients with chronic rena! insufficiency presented by Vincent,
Pozet and Revillard [2], using their mathematical kinetic model,
and have determined the value to be 0.152 0.016 mg/hr/kg for
their patients on hemodialysis.
Karisson et al [3] and Odell et a! [6] described no significant
difference in the 2m generation rate between normal persons and
patients with renal diseases.
The aim of the present study is to reveal the principal factors
dominating 2m deposition and to estimate its deposition rate.
The difference in /32m generation rates found in previous publi-
cations and also between patients is not essential in the present
study. Therefore, the 2m generation rate (G) in the present study
was fixed at 0.131 mg/hr/kg because the present mathematical
kinetic model was based on the model Karlsson et a! [3] have
proposed. The dry weight of 60 kg per patient gave 0.131 mg/mm
to G. The extrarenal disappearance rate (KER) was regarded as
1 ml/min in a similar manner as found in the literature [3].
The concentrations of the intra- and extravascular fluids (C1
and CE) are illustrated in Figure 2 with the continuous line and
plots, respectively. The time courses of 132m concentrations in
each fluid were almost the same. Dilution caused by water intake
and concentration by filtration during hemodialysis treatment
gave slight variations in the time courses. The concentration
reached the maximum value of 137 mg/liter at the end of each
treatment and a minimum value of 123 mg/liter at the beginning
of each Monday treatment.
Time-averaged concentration in plasma (TACI) is defined by
TAC1 = l/tD f C1dt, (7)
where tD (mm) denotes an appropriate period for averaging C1,
which is usually one week in steady state. The values of TACJ
calculated from Eq. 7 with the values of C1 obtained by the
mathematical kinetic model at varying G and KER were in fair
agreement with the values of C1 calculated from Eq. 6, leading to
the validity of Eq. 6 and the assumption that C1 was nearly
constant in a patient without residual renal function who was
treated with conventional dialyzers.
The level of C1 shown in Figure 2, which is equal to plasma 2m
concentration, is much higher than that reported in previous
papers. For example, plasma 2m concentrations of three patients
without renal creatinine clearance at the beginning of treatment
with conventional dialyzers [4] provide a mean value of 75.7
mg/liter. It is apparent from Eq. 6 that the discrepancy is caused
by overestimating G or underestimating KER.
As discussed above, the value of 0.131 mg/hr/kg is suitable for
the /32m generation rate (G) of a patient without residual renal
function, leading to an assumption that disappearance due to
deposition into organs and tissues in the patient's body seemingly
increases the value of KER in the patient. Therefore, 132m
deposition rate m (mg/mm) can be estimated with the following
equation derived from Eq. 6:
mD = KDCT = G — KER'CI (8)
where KD (m!/min) denotes the J32m disappearance rate due to
deposition and KER' (ml/min) net extrarenal disappearance rate
defined by
KER' = KER — KD (9)
Consequently, determination of G and KER' of a patient
enables one to estimate a (.2m deposition rate into the patient
body by Eq. 8. Deposition amounts per year MD (g/year) were
calculated from Eq. 8 at G = 0.131 mg/mm and C1 = TAC1, and
are shown in Figure 3 as a function of TAC1.
Calculation by the present model with the mean plasma f32m
concentration of 75.7 mg/liter described above and with the
generation rate of 0.13 1 mg/mm provided 1.64 mI/mm for KER. If
KER' is equal to 1 mI/mm in this case, the /32m deposition amount
per year in the patient body is estimated as 29 g from Eq. 8.
In practice, it is extremely difficult to determine KER' of a
normal person because the very small value of KER' compared
with renal disappearance rate (KR) includes much measurement
error. Maeda et a! [4] have reported generation and extrarenal
disappearance rates for patients without renal 132mclearance, but
all the values do not satisfy Eq. 6. Though these values were
regarded as constant for each patient and were obtained in a
nonsteady state, the extrarenal disappearance rate might depend
on time.
j32,n removal by treatment with a high performance dialyzer
Time courses of the /32m concentration for a patient treated
with high performance dialyzers are also obtainable from the
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mathematical kinetic model. Figure 4 shows such time courses
during four weeks calculated for the patient described above after
changing treatment with conventional dialyzers for that with high
performance dialyzers with a diffusion clearance (CLD) of 30
mI/mm. The treatment modality was the same as treatment with
the conventional dialyzer.
Intra- and extravascular 2m concentrations (C1, CE) at the
beginning of the first treatment with the high performance
dialyzer were equilibrated at 75.7 mg/liter. Extrarenal disappear-
Fig. 7. Dependence of deposition rates of /32m (M0) on net extrarenal
disappearance rate (KER') and dijJhsive clearance of dialyzers (CLD).
ance rate (KER) and generation rate (G) were 1.64 mI/mm and
0.131 mg/mm, respectively, in a similar manner as above.
There were two types of concentration rebound in the time
courses after each treatment observed clinically 4], which were
caused by mass transfer resistance of the wall between intra- and
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Fig. 4. Time courses of intra- and extravascular
concentration of f32m and extracellular fluid
volume in a patient after changing treatment with
conventional dialyzers to that with high
performance dialyzers. Symbols are (—) C1; (0)
CE.
Fig. 5. Effect of increasing treatment time T0
and diffusive clearance of a dialyzer C,/) on
C,,,,,, for 2m.
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Fig. 6. Removal and deposition rates of /32m, MR and M versus diffusive
clearance of dialyzers CLV. 0 1.0
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extravascular compartments and by /32m generation in the intra-
vascular compartment.
Time courses obtained by the present model reach another
steady state in about one month, but it seems to be shorter than
is practical. An increase in the generation rate, decrease in the
extrarenal disappearance rate and extrication from deposit due to
a decrease in concentration may cause the discrepancy. The
following results and discussion concerning a steady state are not
influenced by the discrepancy observed only in a nonsteady state.
Concentration at the end of each treatment decreases with
decreasing distribution volume of /32m, which corresponds to
extracellular volume (V1 + V) in the present model. Karisson et
a! [3] have reported the distribution volume to be 58.8 mI/kg for
normal persons and 52.3 mI/kg for patients with renal diseases.
However, these values are too small because plasma 2m concen-
tration (C1) at the end of each treatment calculated from the
present model with these values was 4 mg/liter, which was too
low compared with practical values. The distribution volume of
200 ml/kg, equal to extracellular volume, provided reasonable
values of the concentration (Fig. 4). Odell et al [6] have also
estimated the distribution volume of f32m at 200 30 ml/kg.
In steady state, plasma /32m concentration reaches a maximum
value mg/liter) at the beginning of the treatment after the
longest interdialytic period, similarly to other ordinary solutes
[12]. In the case of the above patient, Csrnax is provided at the
beginning of each Monday treatment. Figure 5 represents Cs,,,ax of
the patient versus each treatment time (TD, hr) with varying CLD.
The result theoretically supports the many reports that no pre-
treatment plasma 2m concentration is ever lower than 20 mgI
liter by any treatment modality.
The removal rate by treatment and deposition rate in a patient
body of f32m are equal to CLCI and KDCI, respectively. Removal
and deposition amounts of 2m per year for the above patient
(MR, g/year and MD, g/year), were estimated with varying CL and
KER', and with values of C1 calculated from the present model.
Figure 6 represents C,,,ax, MR and MD versus CLD at KER =
1.64ml/min and KER' = 1 ml/min for the above patient. The effect
of increasing CLD on lowering Csmax was reduced at a higher CLD,
leading to a slight reduction in the rate of increase in MR with
increasing CLD at higher CLD.
Values of MD at varying CLO for the patient are shown versus
KER' in Figure 7. Values of MR and TACJ were constant for each
CLD, that is, 35 g/year and 47 mg/liter at CLD = 30 ml/min, 39
g/year and 44 mg/liter at 50 ml/min, and 41 g/year and 42 mg/liter
at 70 ml/min, respectively. That KER' strongly influences a
deposition rate of f32m but CLD does not may be reasonable for
the difference between patients in the effects of high performance
dialyzers on long-term complications induced by hemodialysis,
such as amyloidosis, in spite of the same treatment modality.
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